← FDA DRUG APPROVALS

FDA ANDA · ANDA074493

CAPTOPRIL

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA074493
TYPE
ANDA
ORIGINAL APPROVAL
1996-02-13
LATEST ACTION
1998-02-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CAPTOPRILDiscontinued
CAPTOPRIL 50MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 12.5MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 100MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 25MG · TABLET · ORAL

Approval history

1998-02-24Manufacturing (CMC) · Supplement 4AP
1997-11-26Manufacturing (CMC) · Supplement 1AP
1997-11-26Manufacturing (CMC) · Supplement 2AP
1997-10-03Labeling · Supplement 3AP
1996-02-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →